Investor insights
Sectors invested in
Biotechnology3
Health Care3
Pharmaceutical2
Biopharma2
Huntington's Disease1
Rare Diseases1
Pharmaceuticals1
RNAi1
Medical1
Biotech1
Drug Development1
Therapeutics1
Life Science1
Genetics1
Friedrich's Ataxia1
Alzheimer's disease1
Neurology1
Research1
Neuropharmacology1
Gene Therapy1
Funding rounds participated in
$25M sweet spot round size
Most of their 4 investments are in rounds between $12M and $30M
Basic info
Sectors
Biotechnology
Genetics
Biopharma
Date founded
1981
Investments made
V
Voyager Therapeutics, Inc. raised $30M on February 11, 2015
Investors: Genzyme
A
Alnylam Pharmaceuticals raised $700M on January 13, 2014
Investors: Genzyme
H
Humanigen, Inc. raised $20M on September 23, 2008
Investors: Sofinnova Ventures, Russia technology fund, Alloy Ventures, GBS Venture Partners, MPM Capital, 5AM Ventures and Genzyme
U
Undisclosed raised $12M on June 7, 2006
Investors: MPM Capital, Vanguard Ventures, Prism Venture Partners and Genzyme